PharmaTimes March 4, 2024
Jen Brogan

Around 900,000 people in the UK are affected by the progressive neurodegenerative disease

Researchers from University College London (UCL), in collaboration with the University of Cambridge, have revealed that impaired spatial navigation could determine the risk of Alzheimer’s disease (AD) before the onset of symptoms.

Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, researchers used virtual reality (VR) to test the spatial navigation of 100 asymptomatic adults from the PREVENT-Dementia study.

Affecting around 900.000 people in the UK, AD is a neurodegenerative disorder that progressively destroys memory, thinking skills and the ability to carry out simple day-to-day tasks.

Researchers recruited adults aged between 43 and 66 years who had a hereditary or physiological risk of AD related...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Metaverse/VR, Provider, Survey / Study, Technology, Trends
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
Old Dominion University, HaptX, Georgia Tech receive grant for VR for the visually impaired
FDA initiative puts AR/VR at heart of home health drive
Meta's Reality Labs posts $3.85 billion loss in first quarter
Meta Aims to Ignite Enterprise Productivity With Open Metaverse OS

Share This Article